The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Open accessAbstract
Antiviral therapy is urgently needed to combat the coronavirus disease 2019 (COVID-19) pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The protease inhibitor camostat mesylate inhibits SARS-CoV-2 infection of lung cells by blocking the virus-activating host cell protease TMPRSS2. Camostat mesylate has been approved for treatment of pancreatitis in Japan and is currently being repurposed for COVID-19 treatment. However, potential mechanisms of viral resistance as well as camostat mesylate metabolization and antiviral activity of metabolites are unclear. Here, we show that SARS-CoV-2 can employ TMPRSS2-related host cell proteases for activation and that several of them are expressed in viral target cells. However, entry mediated by these proteases was blocked by camostat mesylate. The camostat metabolite GBPA inhibited the activity of recombinant TMPRSS2 with reduced efficiency as compared to camostat mesylate and was rapidly generated in the presence of serum. Importantly, the infection experiments in which camostat mesylate was identified as a SARS-CoV-2 inhibitor involved preincubation of target cells with camostat mesylate in the presence of serum for 2 h and thus allowed conversion of camostat mesylate into GBPA. Indeed, when the antiviral activities of GBPA and camostat mesylate were compared in this setting, no major differences were identified. Our results indicate that use of TMPRSS2-related proteases for entry into target cells will not render SARS-CoV-2 camostat mesylate resistant. Moreover, the present and previous findings suggest that the peak concentrations of GBPA established after the clinically approved camostat mesylate dose (600 mg/day) will result in antiviral activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Self-citationDexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852 · cited 1×
“Further, we used pCG1-based expression vectors for human ACE2 [27] and a SARS-2-S variant with a truncated cytoplasmic tail for improved pseudotype particle production (deletion of last 18 amino acid residues [28].”
Self-citationMultiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 2×
“A recent study provided evidence for extrapulmonary replication of SARS-CoV-2 in liver, colon, heart, kidney and blood in some patients [17].”
A molecular cell atlas of the human lung from single-cell RNA sequencing
Travaglini, K. J., Nabhan, A. N., Penland, L., Sinha, R., Gillich, A., Sit, R. V., Chang, S., Conley, S. D., Mori, Y., Seita, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2922-4 · Cited by 1,691
Remdesivir for the Treatment of Covid-19 — Preliminary Report
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,396
Markov models of molecular kinetics: Generation and validation
Prinz, J.-H., Wu, H., Sarich, M., Keller, B., Senne, M., Held, M., Chodera, J. D., Schütte, C., & Noé, F. (2011) · The Journal of Chemical Physics · doi:10.1063/1.3565032 · Cited by 1,275 · cited 1×
“We have re-evaluated the Markov model [31] presented by Hempel and colleagues [32] to compare the dominant metastable TMPRSS2 binding mode populations of GBPA (Fig.”
Self-citationReyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
Sungnak, W., Huang, N., Bécavin, C., & Berg, M. (2020) · PubMed Central · Cited by 1,196
Lukassen, S., Chua, R. L., Trefzer, T., Kahn, N. C., Schneider, M. A., Muley, T., Winter, H., Meister, M., Veith, C., Boots, A. W., et al. (2020) · The EMBO Journal · doi:10.15252/embj.20105114 · Cited by 1,100
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,076
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019) · Journal of Virology · doi:10.1128/jvi.01815-18 · Cited by 618
Protease inhibitors targeting coronavirus and filovirus entry
Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.011 · Cited by 583
Self-citationThe Genotype-Tissue Expression (GTEx) Project
Carithers, L. J., & Moore, H. M. (2015) · Biopreservation and Biobanking · doi:10.1089/bio.2015.29031.hmm · Cited by 549 · cited 1×
“Therefore, we asked whether ACE2, TMPRSS2 and related SARS2-S-activating proteases are expressed in these organs, using published resources [34,49].”
Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012) · Journal of Virology · doi:10.1128/jvi.00094-12 · Cited by 515
A single-cell atlas of the human healthy airways
Deprez, M., Zaragosi, L.-E., Truchi, M., Garcia, S. R., Arguel, M.-J., Lebrigand, K., Paquet, A., Pee’r, D., Marquette, C.-H., Leroy, S., et al. (2019) · doi:10.1101/2019.12.21.884759 · Cited by 493
Böttcher, E., Matrosovich, T., Beyerle, M., Klenk, H.-D., Garten, W., & Matrosovich, M. (2006) · Journal of Virology · doi:10.1128/jvi.01118-06 · Cited by 489
Shirato, K., Kawase, M., & Matsuyama, S. (2013) · Journal of Virology · doi:10.1128/jvi.01890-13 · Cited by 453
Smith, J. C., Sausville, E. L., Girish, V., Yuan, M. L., Vasudevan, A., John, K. M., & Sheltzer, J. M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.012 · Cited by 415
Self-citationCoronavirus Disease (COVID-19)
Glass, C. A., Cash, J. C., & Mullen, J. (2020) · Family Practice Guidelines · doi:10.1891/9780826153425.0016b · Cited by 358
Gierer, S., Bertram, S., Kaup, F., Wrensch, F., Heurich, A., Krämer-Kühl, A., Welsch, K., Winkler, M., Meyer, B., Drosten, C., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00128-13 · Cited by 341
Self-citationBertram, S., Glowacka, I., Müller, M. A., Lavender, H., Gnirss, K., Nehlmeier, I., Niemeyer, D., He, Y., Simmons, G., Drosten, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05300-11 · Cited by 329
Self-citationProteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
Park, J.-E., Li, K., Barlan, A., Fehr, A. R., Perlman, S., McCray, P. B., & Gallagher, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608147113 · Cited by 307
Berger Rentsch, M., & Zimmer, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025858 · Cited by 269
The Genotype-Tissue Expression (GTEx) project
Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2653 · Cited by 263
Qian, Z., Dominguez, S. R., & Holmes, K. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076469 · Cited by 242
Muus, C., Luecken, M. D., Eraslan, G., Waghray, A., Heimberg, G., Sikkema, L., Kobayashi, Y., Vaishnav, E. D., Subramanian, A., Smilie, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.19.049254 · Cited by 236
Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin
Chaipan, C., Kobasa, D., Bertram, S., Glowacka, I., Steffen, I., Solomon Tsegaye, T., Takeda, M., Bugge, T. H., Kim, S., Park, Y., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02205-08 · Cited by 223
A molecular cell atlas of the human lung from single cell RNA sequencing
Travaglini, K. J., Nabhan, A. N., Penland, L., Sinha, R., Gillich, A., Sit, R. V., Chang, S., Conley, S. D., Mori, Y., Seita, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/742320 · Cited by 216
LungMAP: The Molecular Atlas of Lung Development Program
Ardini-Poleske, M. E., Clark, R. F., Ansong, C., Carson, J. P., Corley, R. A., Deutsch, G. H., Hagood, J. S., Kaminski, N., Mariani, T. J., Potter, S. S., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00139.2017 · Cited by 212
Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
Hatesuer, B., Bertram, S., Mehnert, N., Bahgat, M. M., Nelson, P. S., Pöhlman, S., & Schughart, K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003774 · Cited by 198
Limburg, H., Harbig, A., Bestle, D., Stein, D. A., Moulton, H. M., Jaeger, J., Janga, H., Hardes, K., Koepke, J., Schulte, L., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00649-19 · Cited by 170
Sakai, K., Ami, Y., Tahara, M., Kubota, T., Anraku, M., Abe, M., Nakajima, N., Sekizuka, T., Shirato, K., Suzaki, Y., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03677-13 · Cited by 165
Jung, H., Lee, K., Park, S. J., Park, J., Jang, Y.-S., Choi, S.-Y., Jung, J.-G., Jo, K., Park, D. Y., Yoon, J.-H., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210914 · Cited by 157
Tarnow, C., Engels, G., Arendt, A., Schwalm, F., Sediri, H., Preuß, A., Nelson, P. S., Garten, W., Klenk, H. D., Gabriel, G., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03799-13 · Cited by 153
Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety
Breining, P., Frølund, A. L., Højen, J. F., Gunst, J. D., Stærke, N. B., Sædder, E. A., Cases, M., Little, P. S., Nielsen, L. P., Søgaard, O. S., et al. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13533 · Cited by 145
Self-citationHempel, T., Raich, L., Olsson, S., Azouz, N. P., Klingler, A. M., Hoffmann, M., Pöhlmann, S., Rothenberg, M. E., & Noé, F. (2020) · Chemical Science · doi:10.1039/d0sc05064d · Cited by 119
Self-citationHoffmann, M., Müller, M. A., Drexler, J. F., Glende, J., Erdt, M., Gützkow, T., Losemann, C., Binger, T., Deng, H., Schwegmann‐Weßels, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072942 · Cited by 114
Self-citationDESC1 and MSPL Activate Influenza A Viruses and Emerging Coronaviruses for Host Cell Entry
Zmora, P., Błażejewska, P., Moldenhauer, A.-S., Welsch, K., Nehlmeier, I., Wu, Q., Schneider, H., Pöhlmann, S., & Bertram, S. (2014) · Journal of Virology · doi:10.1128/jvi.01427-14 · Cited by 92
Self-citationRepurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
Santos, J. L., Brierley, S. F., Gandhi, M. J., Cohen, M. A., Moschella, P., & Declan, A. B. L. (2020) · Viruses · doi:10.3390/v12070705 · Cited by 59
Laporte, M., Stevaert, A., Raeymaekers, V., Boogaerts, T., Nehlmeier, I., Chiu, W., Benkheil, M., Vanaudenaerde, B. M., Pöhlmann, S., & Naesens, L. M. J. (2019) · Journal of Virology · doi:10.1128/jvi.01430-19 · Cited by 56
Self-citationNeuhaus, V., Danov, O., Konzok, S., Obernolte, H., Dehmel, S., Braubach, P., Jonigk, D. D., Fieguth, H., Zardo, P., Warnecke, G., et al. (2018) · Journal of Visualized Experiments · doi:10.3791/57042 · Cited by 55
Self-citationZmora, P., Hoffmann, M., Kollmus, H., Moldenhauer, A.-S., Danov, O., Braun, A. C., Winkler, M., Schughart, K., & Pöhlmann, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001273 · Cited by 55
Self-citationKühn, N., Bergmann, S., Kösterke, N., Lambertz, R. L. O., Keppner, A., van den Brand, J. M. A., Pöhlmann, S., Weiß, S., Hümmler, E., Hatesuer, B., et al. (2016) · Journal of Virology · doi:10.1128/jvi.02693-15 · Cited by 51
Self-citationBrinkmann, C., Hoffmann, M., Lübke, A., Nehlmeier, I., Krämer-Kühl, A., Winkler, M., & Pöhlmann, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189073 · Cited by 48
Self-citationCamostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation
Hofmann-Winkler, H., Moerer, O., Alt-Epping, S., Bräuer, A., Büttner, B., Müller, M., Fricke, T., Grundmann, J., Harnisch, L.-O., Heise, D., et al. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000284 · Cited by 48
Self-citationMetabolic fate of14C-camostat mesylate in man, rat and dog after intravenous administration
Midgley, I., Hood, A. J., Proctor, P., et al. (1994) · Xenobiotica · doi:10.3109/00498259409043223 · Cited by 47
Rensi, S., Altman, R. B., Liu, T., Lo, Y., McInnes, G., Derry, A., & Keys, A. M. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12009582.v1 · Cited by 47
Harbig, A., Mernberger, M., Bittel, L., Pleschka, S., Schughart, K., Steinmetzer, T., Stiewe, T., Nist, A., & Böttcher‐Friebertshäuser, E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012635 · Cited by 44
Sakai, K., Sekizuka, T., Ami, Y., Nakajima, N., Kitazawa, M., Sato, Y., Nakajima, K., Anraku, M., Kubota, T., Komase, K., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00124-15 · Cited by 35
Ramjee, M. K., Henderson, I. M. J., McLoughlin, S. B., & Padova, A. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00206-1 · Cited by 34
New Orally Active Serine Protease Inhibitors
Senokuchi, K., Nakai, H., Nakayama, Y., Odagaki, Y., Sakaki, K., Kato, M., Maruyama, T., Miyazaki, T., Ito, H., Kamiyasu, K., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00014a003 · Cited by 29
Sakai, K., Ami, Y., Nakajima, N., Nakajima, K., Kitazawa, M., Anraku, M., Takayama, I., Sangsriratanakul, N., Komura, M., Sato, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep29430 · Cited by 24
Cited by
Lamers, M. M., & Haagmans, B. L. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00713-0 · Cited by 983
Structural biology of SARS-CoV-2: open the door for novel therapies
Yan, W., Zheng, Y., Zeng, X., He, B., & Cheng, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00884-5 · Cited by 291
Hoffmann, M., Hofmann-Winkler, H., Krüger, N., Kempf, A., Nehlmeier, I., Graichen, L., Arora, P., Sidarovich, A., Moldenhauer, A.-S., Winkler, M. S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109415 · Cited by 258
Self-citationBiering, S. B., Van Dis, E., Wehri, E., Yamashiro, L. H., Wrynla, X. H., Dugast-Darzacq, C., Graham, T. G. W., Stroumza, J. R., Golovkine, G. R., Roberts, A. W., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00017 · Cited by 28
Lawrenz, J., Wettstein, L., Rodríguez Alfonso, A., Nchioua, R., von Maltitz, P., Albers, D. P. J., Zech, F., Vandeput, J., Naesens, L., Fois, G., et al. (2025) · Advanced Science · doi:10.1002/advs.202506430 · Cited by 8
Metadata
- Authors
- Hoffmann, M., Hofmann-Winkler, H., Smith, J. C., Krüger, N., Arora, P., Sørensen, L. K., Søgaard, O. S., Hasselstrøm, J. B., Winkler, M., Hempel, T., Raich, L., Olsson, S., Danov, O., Jonigk, D., Yamazoe, T., Yamatsuta, K., Mizuno, H., Ludwig, S., Noé, F., Kjolby, M., Braun, A., Sheltzer, J. M., & Pöhlmann, S.
- Venue
- EBioMedicine
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 65
- Pages
- 103255
- ISSN
- 2352-3964 (ISSN-L)
- OpenAlex
- W3133812656
- Cited by
- 385
- References
- 60
- FWCI
- 22.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.